Prosecution Insights
Prosecution Insights
2 pending office actions • 0 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Isola Therapeutics Inc. manages a company patent portfolio that currently includes 1 pending office action. This action is assigned to 1 distinct examiner. The data shows 0 distinct art units for this current pending activity, which is the current administrative profile for the company's filings.
The busiest examiner for Isola Therapeutics Inc. is BRANDT, DAVID NELSON, who is responsible for 1 pending office action. As the total number of pending office actions is 1, this examiner is the sole point of contact for the company's current pending matters. The combination of 1 distinct examiner and 0 distinct art units describes the current administrative state of the company's prosecution. This concentration means that the company's immediate patent prospects are tied to the review of a single examiner, BRANDT, DAVID NELSON, for this single pending action. Practitioners should focus on this individual examiner relationship as it represents the entirety of the company's current pending workload.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SCHMIDT, EMILY LOUISE | 1 | 58.4% | +36.7% |
| BRANDT, DAVID NELSON | 1 | 70.1% | +49.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18680666 | INTRALUMINAL LOCAL DRUG DELIVERY | SCHMIDT, EMILY LOUISE | — |
| 18444169 | DEVICES AND SYSTEMS FOR INTRALUMINAL LOCAL DRUG DELIVERY | BRANDT, DAVID NELSON | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18680666 | INTRALUMINAL LOCAL DRUG DELIVERY | SCHMIDT, EMILY LOUISE | — |
| 18444169 | DEVICES AND SYSTEMS FOR INTRALUMINAL LOCAL DRUG DELIVERY | BRANDT, DAVID NELSON | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18680666 | INTRALUMINAL LOCAL DRUG DELIVERY | SCHMIDT, EMILY LOUISE | — | §102§103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18444169 | DEVICES AND SYSTEMS FOR INTRALUMINAL LOCAL DRUG DELIVERY | BRANDT, DAVID NELSON | — | §103§112Other | Non-Final OA | — | Pending | Feb 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial